BENIGNO VALDEZ to Salvage Therapy
This is a "connection" page, showing publications BENIGNO VALDEZ has written about Salvage Therapy.
Connection Strength
0.087
-
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma. Biol Blood Marrow Transplant. 2018 08; 24(8):1602-1609.
Score: 0.087